Avinger, Inc. (AVGR)
USD 0.49
(-3.35%)
USD 0.49
(-3.35%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 18.63 Million USD | 0.15% |
| 2022 | 18.61 Million USD | -13.54% |
| 2021 | 21.52 Million USD | 7.51% |
| 2020 | 20.02 Million USD | -9.92% |
| 2019 | 22.22 Million USD | -5.22% |
| 2018 | 23.45 Million USD | -35.64% |
| 2017 | 36.43 Million USD | -34.33% |
| 2016 | 55.48 Million USD | 23.51% |
| 2015 | 44.92 Million USD | 51.13% |
| 2014 | 29.72 Million USD | -28.77% |
| 2013 | 41.73 Million USD | 9.06% |
| 2012 | 38.26 Million USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 4.5 Million USD | -17.07% |
| 2024 Q1 | 5.43 Million USD | 8.88% |
| 2023 Q4 | 4.98 Million USD | 12.85% |
| 2023 FY | 18.63 Million USD | 0.15% |
| 2023 Q2 | 4.33 Million USD | -11.44% |
| 2023 Q1 | 4.89 Million USD | 8.63% |
| 2023 Q3 | 4.42 Million USD | 2.01% |
| 2022 FY | 18.61 Million USD | -13.54% |
| 2022 Q4 | 4.5 Million USD | 0.78% |
| 2022 Q3 | 4.47 Million USD | 1.22% |
| 2022 Q2 | 4.41 Million USD | -15.4% |
| 2022 Q1 | 5.22 Million USD | -0.91% |
| 2021 FY | 21.52 Million USD | 7.51% |
| 2021 Q2 | 5.42 Million USD | -2.13% |
| 2021 Q3 | 5.28 Million USD | -2.51% |
| 2021 Q1 | 5.54 Million USD | 6.33% |
| 2021 Q4 | 5.26 Million USD | -0.4% |
| 2020 Q2 | 3.95 Million USD | -33.93% |
| 2020 Q3 | 4.87 Million USD | 23.46% |
| 2020 Q1 | 5.98 Million USD | 0.71% |
| 2020 Q4 | 5.21 Million USD | 6.87% |
| 2020 FY | 20.02 Million USD | -9.92% |
| 2019 Q2 | 5.42 Million USD | 0.48% |
| 2019 FY | 22.22 Million USD | -5.22% |
| 2019 Q4 | 5.93 Million USD | 8.71% |
| 2019 Q3 | 5.46 Million USD | 0.66% |
| 2019 Q1 | 5.4 Million USD | -15.47% |
| 2018 Q3 | 5.66 Million USD | 5.59% |
| 2018 FY | 23.45 Million USD | -35.64% |
| 2018 Q4 | 6.38 Million USD | 12.8% |
| 2018 Q2 | 5.36 Million USD | -11.16% |
| 2018 Q1 | 6.03 Million USD | -9.38% |
| 2017 Q2 | 9.28 Million USD | -29.87% |
| 2017 Q4 | 6.66 Million USD | -8.11% |
| 2017 Q1 | 13.24 Million USD | 2.29% |
| 2017 FY | 36.43 Million USD | -34.33% |
| 2017 Q3 | 7.25 Million USD | -21.93% |
| 2016 Q4 | 12.94 Million USD | -0.46% |
| 2016 FY | 55.48 Million USD | 23.51% |
| 2016 Q3 | 13 Million USD | -2.42% |
| 2016 Q2 | 13.32 Million USD | -17.77% |
| 2016 Q1 | 16.2 Million USD | 21.34% |
| 2015 FY | 44.92 Million USD | 51.13% |
| 2015 Q2 | 10.49 Million USD | 2.65% |
| 2015 Q1 | 10.22 Million USD | 20.62% |
| 2015 Q4 | 13.35 Million USD | 23.14% |
| 2015 Q3 | 10.84 Million USD | 3.34% |
| 2014 Q2 | 6.94 Million USD | -0.66% |
| 2014 Q3 | 7.3 Million USD | 5.14% |
| 2014 Q4 | 8.47 Million USD | 16.03% |
| 2014 Q1 | 6.99 Million USD | -17.6% |
| 2014 FY | 29.72 Million USD | -28.77% |
| 2013 Q3 | 9.99 Million USD | -13.94% |
| 2013 Q2 | 11.61 Million USD | 0.0% |
| 2013 FY | 41.73 Million USD | 9.06% |
| 2013 Q1 | 11.61 Million USD | 0.0% |
| 2013 Q4 | 8.48 Million USD | -15.09% |
| 2012 FY | 38.26 Million USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Akoya Biosciences, Inc. | 104.27 Million USD | 82.125% |
| AngioDynamics, Inc. | 252.41 Million USD | 92.616% |
| AtriCure, Inc. | 327.05 Million USD | 94.301% |
| Azenta, Inc. | 336.26 Million USD | 94.457% |
| BioLife Solutions, Inc. | 117.57 Million USD | 84.148% |
| The Cooper Companies, Inc. | 1.82 Billion USD | 98.979% |
| Daxor Corporation | 1.28 Million USD | -1355.508% |
| Ekso Bionics Holdings, Inc. | 24.19 Million USD | 22.955% |
| Femasys Inc. | 15.2 Million USD | -22.616% |
| GlucoTrack, Inc. | 7.1 Million USD | -162.359% |
| Harvard Bioscience, Inc. | 58.58 Million USD | 68.184% |
| Hologic, Inc. | 1.34 Billion USD | 98.614% |
| ICU Medical, Inc. | 717.04 Million USD | 97.401% |
| Intuitive Surgical, Inc. | 2.96 Billion USD | 99.371% |
| KORU Medical Systems, Inc. | 26.1 Million USD | 28.612% |
| LeMaitre Vascular, Inc. | 90.33 Million USD | 79.368% |
| Innovative Eyewear, Inc. | -119.32 Thousand USD | 15719.003% |
| Innovative Eyewear, Inc. | -119.32 Thousand USD | 15719.003% |
| Masimo Corporation | 867 Million USD | 97.85% |
| Microbot Medical Inc. | 9.85 Million USD | -89.122% |
| Meihua International Medical Technologies Co., Ltd. | 18.42 Million USD | -1.183% |
| Merit Medical Systems, Inc. | 459.92 Million USD | 95.948% |
| Nephros, Inc. | 9.78 Million USD | -90.495% |
| NovoCure Limited | 613.92 Million USD | 96.964% |
| NEXGEL, Inc. | 4.09 Million USD | -355.029% |
| NEXGEL, Inc. | 4.09 Million USD | -355.029% |
| Singular Genomics Systems, Inc. | 102.24 Million USD | 81.771% |
| OraSure Technologies, Inc. | 125.34 Million USD | 85.13% |
| Pro-Dex, Inc. | 7.37 Million USD | -152.616% |
| Pulse Biosciences, Inc. | 43.57 Million USD | 57.227% |
| Predictive Oncology Inc. | 15.22 Million USD | -22.381% |
| Precision Optics Corporation, Inc. | 8.52 Million USD | -118.702% |
| QuidelOrtho Corporation | 1.35 Billion USD | 98.625% |
| Repligen Corporation | 261.12 Million USD | 92.862% |
| Sanara MedTech Inc. | 61.12 Million USD | 69.509% |
| STAAR Surgical Company | 224.55 Million USD | 91.7% |
| Sharps Technology, Inc. | 10.12 Million USD | -84.049% |
| Utah Medical Products, Inc. | 13.26 Million USD | -40.547% |
| DENTSPLY SIRONA Inc. | 1.79 Billion USD | 98.961% |
| Jin Medical International Ltd. | 3.91 Million USD | -375.754% |